Home
Storia in 1 fonti
Adaptive Biotechnologies Business Separation May Unlock Greater Value - Adaptive Biotechnologies (NASDAQ:
William Blair says Adaptive's Immune Medicine separation could sharpen the MRD story, improve flexibility and support valuation.
Raccontata da
benzinga.com
Timeline cronologica
- ·
Adaptive Biotechnologies Stock Rises On Plan To Split MRD, Immune Medicine Businesses - Adaptive Biotechn
Adaptive Biotechnologies plans to separate its businesses as clonoSEQ profitability and revenue growth accelerate.
- ·
Adaptive Biotechnologies Business Separation May Unlock Greater Value - Adaptive Biotechnologies (NASDAQ:
William Blair says Adaptive's Immune Medicine separation could sharpen the MRD story, improve flexibility and support valuation.